Cell therapy demonstrates promise for acute respiratory distress syndrome - But which cell is best?

Stem Cell Research and Therapy

Volumn 4, Issue 2, 2013, Pages

  Curley, Gerard F ^a   Laffey, John G ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE HEART INFARCTION; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; BRAIN ISCHEMIA; CELL DENSITY; CELL DIFFERENTIATION; CELL REGENERATION; CELL THERAPY; CLINICAL EFFECTIVENESS; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNE RESPONSE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SAFETY; TREATMENT RESPONSE; ANIMAL; BONE MARROW TRANSPLANTATION; CYTOLOGY; LUNG INJURY;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; LUNG INJURY;

EID: 84875550714     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt179     Document Type: Review

References (11)

1. Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model. Rojas M, Parker RE, Thorn N, Corredor C, Iyer SS, Bueno M, Mroz L, Cardenes N, Mora AL, Stecenko AA, Brigham KL, Stem Cell Res Ther 2013 4 26 10.1186/scrt174 23497755
2. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D, Laffey JG, Thorax 2012 67 496 501 10.1136/thoraxjnl-2011-201059 22106021
3. Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome-hope or hype? Hayes M, Curley G, Ansari B, Laffey JG, Crit Care 2012 16 205 10.1186/cc10570 22424108
4. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ, Leukemia 2005 19 1118 1127 10.1038/sj.leu.2403796 15902288 (Pubitemid 40945992)
5. Bone marrow mononuclear cell therapy led to alveolar-capillary membrane repair, improving lung mechanics in endotoxin-induced acute lung injury. Prota LF, Lassance RM, Maron-Gutierrez T, Castiglione RC, Garcia CS, Santana MC, Souza-Menezes J, Abreu SC, Samoto V, Santiago MF, Capelozzi VL, Takiya CM, Rocco PR, Morales MM, Cell Transplant 2010 19 965 971 10.3727/096368910X506845 20447341
6. Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation? Cuende N, Rico L, Herrera C, Stem Cells Transl Med 2012 1 403 408 10.5966/sctm.2011-0064 23197819
7. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P, Circulation 2002 106 1913 1918 10.1161/01.CIR.0000034046.87607.1C 12370212 (Pubitemid 35176294)
8. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Piñero P, Espigado I, Garcia-Solis D, Cayuela A, Montaner J, Boada C, Rosell A, Jimenez MD, Mayol A, Gil-Peralta A, Stroke 2012 43 2242 2244 10.1161/STROKEAHA.112.659409 22764211
9. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, Breguet R, Lanthier N, Farina A, Passweg J, Becker CD, Hadengue A, PLoS One 2013 8 53719 10.1371/journal.pone.0053719 23341981
10. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. Hare JM, Fishman JE, Gerstenblith G, Difede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, JAMA 2012 308 2369 2379 23117550
11. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S, Circulation 2004 109 1615 1622 10.1161/01.CIR.0000124476.32871.E3 15037527 (Pubitemid 38451717)